Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients.
Moreno-Muñoz D, de la Haba-Rodríguez JR, Conde F, López-Sánchez LM, Valverde A, Hernández V, Martínez A, Villar C, Gómez-España A, Porras I, Rodríguez-Ariza A, Aranda E.
Moreno-Muñoz D, et al. Among authors: aranda e.
Eur J Clin Invest. 2015 Dec;45(12):1325-32. doi: 10.1111/eci.12557. Epub 2015 Nov 20.
Eur J Clin Invest. 2015.
PMID: 26509357